Reality of the prescription and degree of compliance regarding calcium + vitamin D supplements in the treatment of osteoporosis in Primary Care of Andalusia. SOL-D8 Study;Realidad de la prescripción y grado de cumplimiento de los suplementos de calcio + vitamina D en el tratamiento de la osteoporosis en la Atención Primaria de Andalucía. Estudio SOL-D8

Semergen

Volumn 34, Issue 2, 2008, Pages 52-58

  Sebastian Perez Martinez, J ^a   Gea Velazquez De Castro M T ^b  

^a Zona Básica de Salud Almería ^*  (Spain)

^b Hospital Universitari Sant Joan d'Alacant   (Spain)

Author keywords

Calcium; Compliance; Osteoporosis; Vitamin D

Indexed keywords

EID: 40749096514     PISSN: 11383593     EISSN: 15788865     Source Type: Journal    
DOI: 10.1016/S1138-3593(08)71850-1     Document Type: Article

References (24)

1. Díaz Curiel M, García JJ, Carrasco JL, Honorato J, Pérez Cano R, Rapado A, et al. Prevalencia de osteoporosis determinada por densitometría en la población femenina española. Med Clin (Barc). 2001;116:86-8.
2. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999;353:878-82.
3. Boonen S, Vanderschueren D, Haentjens P, Lips P. Calcium and vitamin D in the prevention and treatment of osteoporosis-clinical update. J Int Med. 2006;259:539-52.
4. Committee for medicinal products for human use (CHMP) of the European Medicines Agency (EMEA).Guideline on the evaluation of new medicinal products in the treatment of primary osteoporosis. CPMP/EWP/552/95 Rev.2.
5. Aguado P, del Campo MT, Garcés MV, González-Casaus ML, Bernad M, Gijón-Baños J, et al. Low vitamin D levels in outpatient postmenopausal women from a rheumatology clinic in Madrid, Spain: Their relationship with bone mineral density. Osteoporos Int. 2000;11:739-44.
6. Quesada-Gómez JM, Alonso J, Bouillon R. Vitamin D insufficiency as a determinant of hip fractures. Osteoporos Int. 1996;Suppl 3:S42-7.
7. Gaugris S, Heaney RP, Boonen S, Kurth H, Bentkover JD, Sen SS. Vitamin D inadequacy among post-menopausal women: a systematic review. QJM. 2005;98:667-76.
8. Reginster JY. The high prevalence of inadequate serum vitamin D levels and implications for bone health. Curr Med Res Opin. 2005;21:579-85.
9. Mezquita Raya P, Muñoz Torres M, López Rodríguez F, Martínez Martín N, Conde Valero A, Ortego Centeno N, et al. Elevada prevalencia de déficit de vitamina D en poblaciones con riesgo de osteoporosis: un factor relevante en la integridad ósea. Med Clin (Barc). 2002;119:85-9.
10. Simonelli C, Weiss TW, Morancey J, Swanson L, Chen YT. Prevalence of vitamin D inadequacy in a minimal trauma fracture population. Curr Med Res Opin. 2005;21:1069-74.
11. Lips P, Hosking D, Lippuner K, Norquist JM, Wehren L, Maalouf G, et al. The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med. 2006;260:245-54.
12. Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT, et al. Prevalence of vitamin D inadequacy among postmenopausal north American women receiving osteoporosis therapy. J Clin Endocrinol Metab. 2005;90:3215-24.
13. Holick MF. Prevalencia elevada de la deficiencia de vitamina D y consecuencias para la salud. Mayo Clin Proc. 2006;81:353-73.
14. Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab. 2001;86:1212-21.
15. Del Campo MT, Aguado P, Martínez ME. Vitamina D y salud ósea: ¿es necesario revisar la administración de sus suplementos en poblaciones de riesgo de osteoporosis? Med Clin (Barc). 2005;125:788-93.
16. National Osteoporosis Foundation. Prevention calcium & vitamin D [Consultado el 19-10-2005). Disponible en: http://www.nof.org/prevention/ calcium.htm
17. Scientific Committee for Food. Reports of the Scientific Committee for Food (Thirty-first series). Office for Official Publications of the European Communities. Luxembourg; 1993.
18. Bayly JR, Hollands RD, Riordan-Jones SE, Yemm SJ, Brough-Williams I, Thatcher M, et al. Prescribed vitamin D and calcium preparations in patients treated with bone remodelling agents in primary care: a report of a pilot study. Curr Med Res Opin. 2006;22:131-7.
19. Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Siurdsson G. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA. 2005;294:2336-41.
20. Berg JS, Dischler J, Wagner DJ, Raia JJ, Palmer-Shevlin N. Medication compliance: a healthcare problem. Ann Pharmacother. 1993;27 Suppl 9:S1-24.
21. Miller NH. Compliance with treatment regimens in chronic asymptomatic diseases. Am J Med. 1997;102:43-9.
22. Sung JC, Nichol MB, Venturini F, Bailey KL, McCombs JS, Cody M. Factors affecting patient compliance with antihyperlipidemic medications in an HMO population. Am J Manag Care. 1998;4:1421-30.
23. Rossini M, Bianchi G, Di Munno O, Giannini S, Minisola S, Sinigaglia L, et al. Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int. 2006;17:914-21.
24. The RECORD Trial Group. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet. 2005;365:1621-8.